GENFIT Logo

GENFIT

GNFT | XPAR

Overview

Corporate Details

ISIN(s):
FR0004163111 (+2 more)
LEI:
969500XPWN2DMZQA5X73
Country:
France
Address:
885 AVENUE EUGENE AVINEE, 59120 LOOS
Sector:
Health Care
Industry:
Biotechnology

Description

GENFIT is a late-stage biopharmaceutical company dedicated to improving the lives of patients with severe chronic liver diseases. GENFIT is a pioneer in the field of nuclear receptor-based drug discovery, with a rich history and strong scientific heritage spanning more than two decades. Today, GENFIT has a robust and diversified pipeline, using different compounds and technologies evaluated at different development stages and in different liver diseases. Leveraging its internal assets and in-house expertise, GENFIT’s R&D is focused on cholestatic diseases and Acute on Chronic Liver Failure (ACLF): two therapeutic areas with significant unmet medical needs. Currently, the ELATIVE™ Phase 3 clinical trial is evaluating elafibranor (elafibranor is an investigational compound that has not been reviewed nor been approved by a regulatory authority) in patients with Primary Biliary Cholangitis (PBC) following a successful Phase 2 clinical trial.

Social Media

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Date Filing Language Size Actions
2025-05-22 22:10
Earnings Release
GENFIT Reports First Quarter 2025 Financial Information
English 163.4 KB
2025-05-22 22:10
Earnings Release
GENFIT : Information financière du premier trimestre 2025
French 146.7 KB
2025-05-20 22:10
Regulatory News Service
GENFIT to receive a €26.5 million milestone payment following the approval of p…
English 143.6 KB
2025-05-20 22:10
Regulatory News Service
GENFIT va recevoir un paiement d’étape de 26,5 millions d’euros à la suite de l…
French 137.3 KB
2025-05-14 22:10
Sustainability Report
GENFIT: Publication of the 2025 Extra-Financial Performance Report (fiscal year…
English 793.3 KB
2025-05-07 22:10
General Meeting Notice
GENFIT : Assemblée Générale Mixte du 17 juin 2025 — modalités de mise à disposi…
French 129.1 KB
2025-05-07 22:10
General Meeting Notice
GENFIT Annual Combined General Meeting of June 17, 2025 — Availability of Prepa…
English 135.6 KB
2025-05-05 07:30
Inside Information Statement
GENFIT présentera ses dernières avancées dans l'ACLF à l’EASL Congress 2025
French 228.8 KB
2025-05-05 07:30
Regulatory News Service
GENFIT to Present Latest ACLF Research at EASL Congress 2025
English 220.7 KB
2025-04-29 21:10
Report Publication Announcement
GENFIT : Mise à disposition du Document d’Enregistrement Universel 2024 et du R…
French 516.5 KB
2025-04-29 21:10
Report Publication Announcement
GENFIT Announces Publication of the 2024 Universal Registration Document and th…
English 648.6 KB
2025-04-29 12:14
Annual Report (ESEF)
Document d'Enregistrement Universel 2024
French 10.4 MB
2025-04-28 22:10
Regulatory News Service
GENFIT : les données positives de la Phase 2 évaluant elafibranor dans la Chola…
French 181.9 KB
2025-04-28 22:10
Inside Information Statement
GENFIT: positive late-breaking Phase 2 data for elafibranor in Primary Sclerosi…
English 189.9 KB
2025-04-24 22:10
Earnings Release
GENFIT Reports Full-Year 2024 Financial Results and Provides Corporate Update
English 282.4 KB

Insider Transactions

Date Insider Name Position Type Shares Value
2023-07-07 N/A Other Buy 5,300 19,488.10 EUR
2023-07-06 N/A Other Buy 1,100 4,048.00 EUR
2023-07-05 N/A Other Buy 10,000 37,061.00 EUR
2023-07-03 N/A Other Buy 5,300 18,769.95 EUR

Peer Companies

Company Country Ticker View
1NKEMIA Logo 1NKEMIA Spain IKM
2cureX AB Logo 2cureX AB Sweden 2CUREX
4SC AG Logo 4SC AG Germany VSC
Abera Bioscience AB Logo Abera Bioscience AB Sweden ABERA
ABIONYX Pharma Logo ABIONYX Pharma France ABNX
Abliva Logo Abliva Sweden ABLI
AB Science Logo AB Science France AB
Acticor Biotech Logo Acticor Biotech France ALACT
Active Biotech Logo Active Biotech Sweden ACTI
AcuCort AB Logo AcuCort AB Sweden ACUC